Detalles de la búsqueda
1.
Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment.
Mol Psychiatry;
2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783053
2.
Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor.
Ann Neurol;
94(4): 713-726, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486023
3.
Transcriptomic risk scores for attention deficit/hyperactivity disorder.
Mol Psychiatry;
28(8): 3493-3502, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537283
4.
Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants.
J Transl Med;
21(1): 272, 2023 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085903
5.
Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments.
Psychol Med;
52(14): 3150-3158, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33531098
6.
Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
Mol Psychiatry;
25(10): 2493-2503, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610198
7.
Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing.
Mol Psychiatry;
25(9): 2047-2057, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30116028
8.
Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
Am J Med Genet B Neuropsychiatr Genet;
186(3): 140-150, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33244849
9.
Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
Mol Psychiatry;
26(7): 3663, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33627840
10.
SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.
J Child Psychol Psychiatry;
58(7): 798-809, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224622
11.
Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder.
Am J Med Genet B Neuropsychiatr Genet;
171(5): 733-47, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27021288
12.
Frustrated expected reward induces differential transcriptional changes in the mouse brain.
Addict Biol;
20(1): 22-37, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25288320
13.
New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder.
Am J Med Genet B Neuropsychiatr Genet;
168(6): 459-470, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26174813
14.
Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.
Am J Med Genet B Neuropsychiatr Genet;
168(6): 480-491, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26174753
15.
On the role of NOS1 ex1f-VNTR in ADHD-allelic, subgroup, and meta-analysis.
Am J Med Genet B Neuropsychiatr Genet;
168(6): 445-458, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26086921
16.
Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.
Transl Psychiatry;
14(1): 221, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811559
17.
Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders.
Psychiatry Res;
333: 115758, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38335780
18.
Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder.
Int J Neuropsychopharmacol;
16(6): 1267-1275, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23363778
19.
Serum brain-derived neurotrophic factor levels and cocaine-induced transient psychotic symptoms.
Neuropsychobiology;
68(3): 146-55, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24051573
20.
Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes.
Int J Epidemiol;
52(2): 386-402, 2023 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690959